1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, United Kingdom
3.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.2 Bone Growth Stimulators Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.3 Cartilage Repair Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.4 Soft Tissue Biologics Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.5 Viscosupplementation Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.2 Bone Growth Stimulators Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.3 Cartilage Repair Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.4 Soft Tissue Biologics Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.5 Viscosupplementation Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033
3.4 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United Kingdom, Orthobiologics Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Sanofi
4.2.1 Company Overview
4.3 Enovis Corp
4.3.1 Company Overview
4.4 Arthrex Inc
4.4.1 Company Overview
4.5 Stryker Corp
4.5.1 Company Overview
4.6 Orthofix Holdings Inc
4.6.1 Company Overview
4.7 Zimmer Biomet Holdings Inc
4.7.1 Company Overview
4.8 Fidia farmaceutici SpA
4.8.1 Company Overview
4.9 Bioventus Inc
4.9.1 Company Overview
 5 Orthobiologics Market Pipeline Products6 Recent Developments
6.1 Corporate Communications
6.1.1 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group
6.2 Financial Announcements
6.2.1 Jan 30, 2025: Tissue Regenix Group Announces Full Year Trading Update
6.2.2 Sep 10, 2024: Tissue Regenix Group Announces Interim Results for Six Months Ended June 30, 2024
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 4: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 5: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 6: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 7: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
Table 8: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Table 9: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
Table 10: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
Table 11: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
Table 12: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
Table 13: Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033
Table 14: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2024
Table 15: Orthobiologics Market Pipeline Products
Table 16: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 4: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 5: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 6: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 7: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
Figure 8: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Figure 9: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
Figure 10: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
Figure 11: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
Figure 12: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
Figure 13: Orthobiologics Market, United Kingdom, Company Share (%), 2024